ENSITRELVIR | N220442 | SHIONOGI INC
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 9150546Newly listed — daily FDA feed, not yet in monthly Orange Book edition | Dec 12, 2030 | — | Yes | Yes | — | — |
| 11814368Newly listed — daily FDA feed, not yet in monthly Orange Book edition | May 1, 2042 | — | Yes | Yes | — | |
| 12559474Newly listed — daily FDA feed, not yet in monthly Orange Book edition | May 1, 2042 | — | Yes | Yes | — |
| Code | Date | Status |
|---|---|---|
| NCENewly listed — daily FDA feed, not yet in monthly Orange Book edition | May 29, 2031 | Active |
Shionogi's XOCOVA (ensitrelvir) received new chemical entity exclusivity expiring May 2031 in the FDA Orange Book.
New: XOCOVA (ENSITRELVIR) — exclusivity NCE exp 05/29/2031